All Articles on COVID-19
Researchers begin trial of nasal spray COVID-19 vaccineKPWHRI is taking part in a clinical trial of a nasal COVID-19 vaccine developed by Boost Biopharma Inc.
Using advanced analytics to prevent adverse COVID-19 outcomesACT Center paper describes a novel predictive model that identifies patients at high risk of hospitalization or death at Kaiser Permanente Washington.
Scientists begin trial of combined COVID-19 and flu vaccineKPWHRI is recruiting Kaiser Permanente Washington members to take part.
COVID risks not meaningfully greater with estrogen-containing medicationsOral contraceptives, hormone therapy not linked to more severe COVID outcomes.
When is Paxlovid right for COVID-19 treatment?New risk model uses advanced analytics to guide informed treatment decisions at Kaiser Permanente Washington.
Top research highlights in 2022From cardiovascular health to cancer screening, these are the research stories that made headlines over the last year.
How did the pandemic impact hospital visits with animals?Top pediatric oncology hospitals reported lasting changes to programs involving visits with animals.
